PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells. Founded by Laurent LEVY in 2014, PDC*line Pharma is backed by Korea Investment Partners, S.R.I.W., Meusinvest (Noshaq), SFPI-FPIM, and Sambrinvest and is headquartered in La Tronche.
FOUNDED:
2014
INDUSTRY:
Biotechnology, Health Care, Therapeutics
FOUNDERS:
Laurent LEVY
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
